Effects of Psilocybin on Mouse Brain Microstructure
Rattachement africain : us, nl, de. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
ABSTRACT BACKGROUND AND PURPOSE: There is surging interest in the therapeutic potential of psychedelic compounds like psilocybin in the treatment of psychiatric illnesses like major depressive disorder (MDD). Recent studies point to the rapid antidepressant effect of psilocybin; however, the biological mechanisms underlying these differences remain unknown. This study determines the feasibility of using diffusion MRI to characterize and define the potential spatiotemporal microstructural differences in the brain following psilocybin treatment in C57BL/6J male mice. MATERIALS AND METHODS: 11-15 week-old C57BL/6J male mice were randomized to receive psilocybin, 6F-DET (6-fluoro-N,Ndiethyltryptamine), or saline and ex vivo imaged 24h (n=18) and 72h (n=18) post treatment. A one-way ANOVA with multiple comparison testing (Bonferroni correction) assessed diffusion metric differences (tractography, DTI, NODDI) between the three groups and was performed in the following regions of interest: amygdala, striatum, hippocampus, thalamus, primary visual cortex area, frontal association cortex, and medial prefrontal cortex at 24h and 72h post drug administration. RESULTS: Psilocybin treated mice demonstrated structural connectivity differences at 72h in the frontal association cortex (compared to saline, mean tract length increases, p=0.03). Psilocybin also induced microstructural differences at 24h post-injection in the primary visual cortex (compared to saline, MD increases, p=0.02) and 72h post-injection in the striatum (compared to saline; MD increases, p= 0.02, NDI decreases, p=0.02) and hippocampus (compared to saline; MD increases, p=0.04, NDI decreases, p=0.02). CONCLUSIONS: Diffusion microstructure imaging and white matter tractography are sensitive methods to detect and characterize the neural substrates and microstructural differences accompanying psilocybin treatment. These findings suggest the potential role for diffusion microstructure imaging to quantify the bioeffects of psychedelics like psilocybin on the brain, monitor treatment response, and identify salient clinical endpoints in an emerging therapeutic option for patients with MDD. ABBREVIATIONS: dMRI= diffusion-weighted MRI; 6F-DET= 6-fluoro-N,N-diethyltryptamine; NODDI= neurite orientation dispersion and density imaging; DTI= diffusion tensor imaging; NDI= neurite density index; ODI= orientation dispersion index; FA= fractional anisotropy; MD= mean diffusivity; MTL= mean tract length; mPFC= medial prefrontal cortex.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Effects of Psilocybin on Mouse Brain Microstructure
- Date Crossref
- 29/01/2025
- Éditeur
- American Society of Neuroradiology (ASNR)
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
University of Wisconsin–Madison pays non établi dans la noticeUniversité ou école supérieure
-
Zimmer Biomet (Netherlands) pays non établi dans la noticeEntreprise
-
Oncoscience (Germany) pays non établi dans la noticeEntreprise
-
Wisconsin Division of Public Health pays non établi dans la noticeÉtablissement de santé
-
University of Wisconsin School of Medicine and Public Health J.-P.J.Y.) pays non établi dans la noticeUniversité ou école supérieure
-
aFrom the Department of Radiology (P.C.F. pays non établi dans la noticeInstitution
-
University of Wisconsin-Madison J.-P.J.Y.) pays non établi dans la noticeUniversité ou école supérieure
-
bGraduate Program in Cellular and Molecular Biology (A.P.S. pays non établi dans la noticeInstitution
-
cNeuroscience Training Program (N.A.S. pays non établi dans la noticeInstitution
-
dDepartment of Psychiatry (N.A.S. pays non établi dans la noticeInstitution
University of Wisconsin–Madison, Zimmer Biomet (Netherlands) et Oncoscience (Germany), avec 7 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.